Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System
Launched by ALMA LASERS · Jan 9, 2019
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects with excessive fat in the lower abdomen or subjects with excessive fat in the outer thighs that are willing to undergo laser-assisted liposuction
- • Estimated fat harvesting of 1-3 liters
- • Subjects (5-20) eligible for facial fat grafting of at least 5 cc for each cheek
- • Between 18 and 70 years of age
- • Provided written Informed Consent
- Exclusion Criteria:
- • Body Mass Index (BMI) \>35
- • Sever skin laxity
- • Positive pregnancy test
- • Current smoker
- • Presence of known malignancy
- • Active infection in the treatment area
- • History of autoimmune disorder (e.g., Systemic Lupus Erythematosus \[SLE\])
- • History of connective, metabolic or atrophic skin disease
- • History of keloid scarring
- • Chronic use (\>7 consecutive days) of anticoagulants (such as aspirin) or NSAIDs within 15 days prior to enrollment
- • Subjects with immune system diseases
- • Subject unable to follow post-treatment instructions
- • Any other reason that in the opinion of the investigator, prevents the subject from participating in the study or compromise the subject safety.
About Alma Lasers
Alma Lasers is a leading global innovator in the development of advanced medical and aesthetic laser technologies. With a commitment to enhancing patient outcomes and practitioner efficiency, the company specializes in a diverse range of laser and energy-based solutions for dermatology, surgery, and aesthetic treatments. Alma Lasers prioritizes research and clinical validation, actively sponsoring clinical trials to advance the efficacy and safety of its products. By fostering collaboration with healthcare professionals and leveraging cutting-edge technology, Alma Lasers continuously aims to set new standards in the medical aesthetics field, ensuring that practitioners have access to the most effective tools for delivering optimal patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boca Raton, Florida, United States
Be'er Ya'aqov, , Israel
Patients applied
Trial Officials
Jason N. Pozner, M.D.
Principal Investigator
Sanctuary Plastic Surgery
Lior Heller, M.D.
Principal Investigator
Yitzhak Shamir Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials